These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37862973)

  • 1. Protective effects and mechanisms of Momordica charantia polysaccharide on early-stage diabetic retinopathy in type 1 diabetes.
    Liu J; Liu Y; Sun J; Guo Y; Lei Y; Guo M; Wang L
    Biomed Pharmacother; 2023 Dec; 168():115726. PubMed ID: 37862973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-κB signaling pathway.
    Raish M
    Int J Biol Macromol; 2017 Apr; 97():544-551. PubMed ID: 28109806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition.
    Raish M; Ahmad A; Ansari MA; Alkharfy KM; Aljenoobi FI; Jan BL; Al-Mohizea AM; Khan A; Ali N
    Int J Biol Macromol; 2018 May; 111():193-199. PubMed ID: 29307809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Notch signaling and angiogenesis via an isolated polysaccharide from Momordica charantia in diabetic rats.
    Sajadimajd S; Mohammadi B; Bahrami G; Madani SH; Hatami R; Miraghaee SS
    J Food Biochem; 2022 Feb; 46(2):e14033. PubMed ID: 34964144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Momordica charantia L. polysaccharide and its protective effect on pancreatic cells injury in STZ-induced diabetic mice.
    Zhang C; Chen H; Bai W
    Int J Biol Macromol; 2018 Aug; 115():45-52. PubMed ID: 29649536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
    Raish M; Ahmad A; Jan BL; Alkharfy KM; Ansari MA; Mohsin K; Jenoobi FA; Al-Mohizea A
    Int J Biol Macromol; 2016 Oct; 91():394-9. PubMed ID: 27238589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway.
    Ji S; Zhang Q
    Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
    Xu X; Shan B; Liao CH; Xie JH; Wen PW; Shi JY
    Int J Biol Macromol; 2015 Nov; 81():538-43. PubMed ID: 26318666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xueshuantong for Injection (Lyophilized, ) Alleviates Streptozotocin-Induced Diabetic Retinopathy in Rats.
    Li RL; Wang JX; Chai LJ; Guo H; Wang H; Chen L; Hu LM; Wang SX
    Chin J Integr Med; 2020 Nov; 26(11):825-832. PubMed ID: 32415646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
    Gao H; Wen JJ; Hu JL; Nie QX; Chen HH; Xiong T; Nie SP; Xie MY
    Carbohydr Polym; 2018 Dec; 201():624-633. PubMed ID: 30241862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway.
    Zhang M; Zhou M; Cai X; Zhou Y; Jiang X; Luo Y; Hu Y; Qiu R; Wu Y; Zhang Y; Xiong Y
    Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36305269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fangchinoline Ameliorates Diabetic Retinopathy by Inhibiting Receptor for Advanced Glycation End-Products (RAGE)-Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB) Pathway in Streptozotocin (STZ)-Induced Diabetic Rats.
    Wu Q; Liu H; Zhou M
    Med Sci Monit; 2019 Feb; 25():1113-1121. PubMed ID: 30739905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Momordica charantia polysaccharide ameliorates D-galactose-induced aging through the Nrf2/β-Catenin signaling pathway.
    Yue J; Guo P; Jin Y; Li M; Hu X; Wang W; Wei X; Qi S
    Metab Brain Dis; 2023 Mar; 38(3):1067-1077. PubMed ID: 36287355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting MiR-34α reduces retinal cell apoptosis and downstream NF-κB pathway in diabetic retinopathy rats through regulating HMGB1 expression.
    Ma Y; DU Y; Xu Q; Bao H; Liu Z; Li Y; Liu W
    Minerva Med; 2023 Feb; 114(1):49-55. PubMed ID: 32683849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechin Weakens Diabetic Retinopathy by Inhibiting the Expression of NF-κB Signaling Pathway-Mediated Inflammatory Factors.
    Wang W; Zhang Y; Jin W; Xing Y; Yang A
    Ann Clin Lab Sci; 2018 Sep; 48(5):594-600. PubMed ID: 30373863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of the Bilobalide on Retinal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Rats.
    Su Q; Dong J; Zhang D; Yang L; Roy R
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6407-6422. PubMed ID: 35932369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction methods, multiple biological activities, and related mechanisms of Momordica charantia polysaccharide: A review.
    Liu J; Guo Y; Sun J; Lei Y; Guo M; Wang L
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130473. PubMed ID: 38423437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
    Wang Q; Wu X; Shi F; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice].
    Li B; Zhang DC; Li XW; Dong XN; Li WP; Li WZ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):476-483. PubMed ID: 35178992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.